Gilva Therapeutics, INC. announced that it will issue 30,000,000 shares at a price of TWD 1 per share for gross proceeds for TWD 30,000,000 on March 5, 2024. The transaction include the participation from new investor Alar Pharmaceuticals Inc. The transaction has been approved at the Board of Directors of the company.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
270 TWD | 0.00% | +12.27% | +28.88% |
1st Jan change | Capi. | |
---|---|---|
+28.88% | 559M | |
+14.99% | 78.65B | |
+9.32% | 8.94B | |
-12.05% | 5.16B | |
+53.66% | 4.85B | |
+11.63% | 4.19B | |
-23.67% | 2.32B | |
+12.07% | 2.29B | |
-32.35% | 2.19B | |
+21.04% | 2.19B |
- Stock Market
- Equities
- 6785 Stock
- News Alar Pharmaceuticals Inc.
- Gilva Therapeutics, INC. announced that it expects to receive TWD 30 million in funding from Alar Pharmaceuticals Inc.